| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +18,333 | +0.88% | $0.000000 | 2,112,616 | 17 Feb 2022 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $348,251 | -8,131 | -0.38% | $42.83 | 2,104,485 | 17 Feb 2022 | Direct | |
| transaction | BSX | Common Stock | Options Exercise | $0 | +16,307 | +0.77% | $0.000000 | 2,120,792 | 18 Feb 2022 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | $307,764 | -7,233 | -0.34% | $42.55 | 2,113,559 | 18 Feb 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -18,333 | -25% | $0.000000 | 55,000 | 17 Feb 2022 | Common Stock | 18,333 | Direct | F1, F3 | |
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -16,307 | -33% | $0.000000 | 32,614 | 18 Feb 2022 | Common Stock | 16,307 | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F3 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. |
| F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. |